Free Trial

Basel Medical Group (BMGL) Competitors

Basel Medical Group logo
$1.95 0.00 (0.00%)
As of 09/9/2025 04:00 PM Eastern

BMGL vs. CORBF, SERA, QIPT, BNR, EUDA, ATPC, BDSX, PIII, KDLY, and MGRX

Should you be buying Basel Medical Group stock or one of its competitors? The main competitors of Basel Medical Group include Global Cord Blood (CORBF), Sera Prognostics (SERA), Quipt Home Medical (QIPT), Burning Rock Biotech (BNR), EUDA Health (EUDA), Agape ATP (ATPC), Biodesix (BDSX), P3 Health Partners (PIII), Kindly MD (KDLY), and Mangoceuticals (MGRX). These companies are all part of the "healthcare" industry.

Basel Medical Group vs. Its Competitors

Global Cord Blood (NYSE:CORBF) and Basel Medical Group (NASDAQ:BMGL) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

Global Cord Blood has higher revenue and earnings than Basel Medical Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Cord Blood$196.12M0.65$79.04MN/AN/A
Basel Medical GroupN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Global Cord BloodN/A N/A N/A
Basel Medical Group N/A N/A N/A

In the previous week, Global Cord Blood's average media sentiment score of 0.00 equaled Basel Medical Group'saverage media sentiment score.

Company Overall Sentiment
Global Cord Blood Neutral
Basel Medical Group Neutral

Summary

Global Cord Blood beats Basel Medical Group on 1 of the 1 factors compared between the two stocks.

Get Basel Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMGL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BMGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BMGL vs. The Competition

MetricBasel Medical GroupMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$35.99M$7.58B$5.83B$10.00B
Dividend YieldN/A2.88%5.29%4.53%
P/E RatioN/A76.5075.6926.28
Price / SalesN/A51.86545.75188.23
Price / CashN/A24.7137.2059.76
Price / BookN/A7.6811.506.41
Net IncomeN/A$238.91M$3.28B$270.56M
7 Day Performance-1.02%4.61%1.42%3.13%
1 Month Performance-6.25%5.21%11.28%9.74%
1 Year PerformanceN/A20.72%59.03%28.17%

Basel Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BMGL
Basel Medical Group
N/A$1.95
flat
N/AN/A$35.99MN/A0.0036
CORBF
Global Cord Blood
N/A$1.05
-40.0%
N/A-30.0%$127.63M$196.12M0.001,200
SERA
Sera Prognostics
1.2261 of 5 stars
$3.23
+4.9%
N/A-57.5%$121.67M$80K-3.80120News Coverage
Positive News
Short Interest ↓
QIPT
Quipt Home Medical
2.7228 of 5 stars
$2.63
flat
$3.15
+19.8%
-4.4%$114.25M$245.91M-10.961,200
BNR
Burning Rock Biotech
0.3211 of 5 stars
$8.55
+3.2%
N/A+94.6%$92.05M$523.28M-4.531,390News Coverage
Earnings Report
Upcoming Earnings
Gap Down
EUDA
EUDA Health
0.5563 of 5 stars
$2.06
-6.8%
N/A-54.3%$76.55M$4.01M0.002Gap Up
ATPC
Agape ATP
0.8298 of 5 stars
$1.31
-2.6%
N/A-17.8%$65.51M$1.32M-3.2040News Coverage
Short Interest ↓
BDSX
Biodesix
3.4355 of 5 stars
$0.43
-4.4%
$1.75
+310.2%
-74.1%$62.55M$76.56M-1.47220Positive News
PIII
P3 Health Partners
3.3654 of 5 stars
$8.28
-0.4%
$16.25
+96.3%
-66.1%$59.53M$1.50B-0.18500News Coverage
Positive News
Short Interest ↓
KDLY
Kindly MD
N/A$5.93
-6.2%
N/A+245.5%$35.71M$2.47M-7.70N/ANews Coverage
Gap Down
MGRX
Mangoceuticals
1.6004 of 5 stars
$2.36
+4.9%
N/A-96.3%$24.87M$620K-0.613

Related Companies and Tools


This page (NASDAQ:BMGL) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners